Description
A selective antagonist of GPR40-mediated Ca2+ elevations in HEK293 cells (pIC50 = 5.99) without effecting those mediated by GPR120 at concentrations up to 10 μM; at 1 μM, inhibits the potentiating effects of GPR agonist, GW 9508 and linoleic acid on glucose-stimulated insulin secretion
Formal name: 4-[5-[(2-ethoxy-5-pyrimidinyl)methyl]-2-[[(4-fluorophenyl)methyl]thio]-4-oxo-1(4H)-pyrimidinyl]-benzoic acid, ethyl ester
Synonyms:
Molecular weight: 520.6
CAS: 306974-70-9
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes